High-tech ‘whole body’ scan could improve treatment of bone marrow cancer — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/01/140128153944.htm
source : http://www.sciencedaily.com/releases/2014/01/140128153944.htm
source : http://www.sciencedaily.com/releases/2014/01/140126134651.htm
source : http://www.sciencedaily.com/releases/2014/01/140124161247.htm
source : http://www.sciencedaily.com/releases/2013/10/131016100428.htm
source : http://www.sciencedaily.com/releases/2013/12/131217134706.htm
source : http://www.sciencedaily.com/releases/2013/12/131217170856.htm
One of the big questions that has concerned biologists working on HIV for two decades now is that of the "effective population size" of the virus within a patient. The effective population size is a mathematical quantity that determines, among other things, how quickly drug resistance may evolve…
Motivated by experiments in the Molecular Neurotology Laboratory at Mass. Eye and Ear involving human tumor specimens, the researchers performed a retrospective analysis of over 600 people diagnosed with vestibular schwannoma at Mass. …
The incidence figures for secondary breast cancer are based on long-term observation of 590 female patients in the German-Austrian pediatric treatment trials dating back to the years 1978 to 1995. The authors estimate that 19% of the girls treated with radiotherapy for Hodgkin’s disease develop secondary breast cancer within 30 years as a result of that therapy. …
Cervical screening programs have until recently relied on cytology to identify women at risk for developing cervical cancer. However, it has long been known that testing screening with human papillomavirus (HPV) DNA tests has a higher sensitivity for cervical intraepithelial neoplasia (CIN), the lesion that the program intends to find since it can progress to cervical cancer if left untreated. Until now, it has been unclear whether HPV-based screening results in overdiagnosis of lesions that would not have progressed to cancer. …